TCP
CVS icon

Tourbillon Capital Partners’s CVS Health CVS Stock Holding History

Tourbillon Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-200,000
Closed -$12.9M – 45
2018
Q2 		$12.9M Buy
+200,000
New +$13.2M 0.5% 51

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Tourbillon Capital Partners's CVS Position: Q3 2018 in Review

Tourbillon Capital Partners sold out of CVS Health (CVS) in Q3 2018, closing a stake of 200,000 shares — an estimated $12.9M sold.

Tourbillon Capital Partners first reported a position in CVS in Q2 2018 and held it in 1 quarter. The position peaked at $12.9M in Q2 2018. 1,600 funds tracked by Wall St. Rank hold CVS as of Q3 2018.

  • Tourbillon Capital Partners reported no remaining CVS Health position as of Q3 2018 after selling out during the quarter.
  • Tourbillon Capital Partners sold 200,000 CVS Health shares in Q3 2018, an estimated $12.9M.
  • Tourbillon Capital Partners first reported a position in CVS Health in Q2 2018 and held it in 1 quarter.
  • Tourbillon Capital Partners's CVS Health position peaked at $12.9M in Q2 2018.
  • 1,600 funds tracked by Wall St. Rank held CVS Health as of Q3 2018.

Based on Tourbillon Capital Partners's 13F filing for Q3 2018, filed 14 Nov 2018.